ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,730.00
-0.11%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vivos Therapeutics Inc (VVOS)

  7. Vivos Therapeutics Inc (VVOS) Noticias

VVOS

Vivos Therapeutics (VVOS)

Vivos Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VVOS
FechaHoraFuenteTítuloSímboloCompañía
09/04/202406:30GlobeNewswire Inc.Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementNASDAQ:VVOSVivos Therapeutics Inc
28/03/202415:05GlobeNewswire Inc.Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
28/03/202406:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
15/02/202407:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
15/02/202407:00GlobeNewswire Inc.Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross ProceedsNASDAQ:VVOSVivos Therapeutics Inc
14/02/202416:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
06/02/202406:30GlobeNewswire Inc.Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth OpportunitiesNASDAQ:VVOSVivos Therapeutics Inc
08/01/202406:30GlobeNewswire Inc.Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSANASDAQ:VVOSVivos Therapeutics Inc
11/12/202306:30GlobeNewswire Inc.Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”NASDAQ:VVOSVivos Therapeutics Inc
03/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VVOSVivos Therapeutics Inc
01/12/202315:12Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:VVOSVivos Therapeutics Inc
30/11/202315:03Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
29/11/202306:30GlobeNewswire Inc.Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep ApneaNASDAQ:VVOSVivos Therapeutics Inc
22/11/202315:46Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VVOSVivos Therapeutics Inc
14/11/202315:05GlobeNewswire Inc.Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
09/11/202315:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
03/11/202316:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VVOSVivos Therapeutics Inc
02/11/202316:00GlobeNewswire Inc.Vivos Therapeutics Closes $4 Million Private PlacementNASDAQ:VVOSVivos Therapeutics Inc
31/10/202307:00GlobeNewswire Inc.Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VVOSVivos Therapeutics Inc
26/10/202306:30GlobeNewswire Inc.Vivos Therapeutics Announces Reverse Stock SplitNASDAQ:VVOSVivos Therapeutics Inc
24/10/202306:30GlobeNewswire Inc.Vivos Therapeutics Signs Nationwide Distribution Agreement with LincareNASDAQ:VVOSVivos Therapeutics Inc
11/10/202306:30GlobeNewswire Inc.Vivos Therapeutics to Begin Clinical Trial at Stanford MedicineNASDAQ:VVOSVivos Therapeutics Inc
05/10/202306:30GlobeNewswire Inc.Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International ExpansionNASDAQ:VVOSVivos Therapeutics Inc
04/10/202314:55AllPennyStocks.comBiotech Soars On New AgreementsNASDAQ:VVOSVivos Therapeutics Inc
04/10/202306:30GlobeNewswire Inc.Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of ProvidersNASDAQ:VVOSVivos Therapeutics Inc
02/10/202306:30GlobeNewswire Inc.New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness ConferenceNASDAQ:VVOSVivos Therapeutics Inc
14/09/202315:38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VVOSVivos Therapeutics Inc
28/08/202308:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VVOSVivos Therapeutics Inc
16/08/202315:45Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VVOSVivos Therapeutics Inc
16/08/202315:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VVOSVivos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VVOS

Su Consulta Reciente

CCOM
US500
US 500
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
FX
USDMXN
US Dollar vs MXN
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados